Cardinal Health (NYSE:CAH) posted second-quarter results today that beat the consensus on Wall Street. The Dublin, Ohio-based company reported profits of $220 million, or 75¢ per share, on sales of $39.7 billion for the three months ended Dec. 31, 2019, for a bottom-line loss of -21.4% sales growth of 5.3% compared with Q2 2019. Adjusted to […]
Boston Scientific posts mixed bag Q4 results
Boston Scientific (NYSE:BSX) posted fourth-quarter results that beat the earnings consensus on Wall Street, but missed on revenue. The Marlborough, Mass.-based company reported profits of $4 billion, or $2.83 per share, on sales of $2.9 billion for the three months ended Dec. 31, 2019, for a bottom-line gain of 935.2% sales growth of 13.43% compared with […]
Zimmer Biomet stock up more than 5% on Street-beating results
Zimmer Biomet (NYSE:ZBH) reported fourth-quarter results today that beat the consensus forecast on Wall Street, announcing a number of new restructuring initiatives. The Warsaw, Ind.–based orthopedic device giant reported profits of $321.4 million, or $1.54 per share, off sales of $2.13 billion for the three months ended Dec. 31, 2019, versus a loss of –$902.5 million, […]
Haemonetics posts Street-beating Q3 results
Haemonetics (NYSE:HAE) posted third-quarter results today that beat the consensus forecast on Wall Street and reaffirmed its total revenue guidance. The news sent shares in HAE up more than 9%. The Boston-based company reported profits of $29.9 million, or 58¢ per share, on sales of $259 million for the three months ended Dec. 31, 2019, for […]
Titan Medical may put itself up for sale
Titan Medical (TSX:TMD) CEO David McNally told shareholders today that the company must raise $85 million to finish developing its Sport robot-assisted surgery device and file for FDA clearance. The Toronto-based medical device company is considering raising that money through equity or debt, licensing, merger or acquisition. Titan Medical lost nearly half its value in October […]
Ex-Sanovas CEO convicted in $2.6m fraud case
A federal jury in San Francisco convicted former Sanovas president & CEO Larry Gerrans this week of wire fraud and money laundering in connection with a scheme to defraud the medical device company. The jury also found Gerrans, 49, of San Anselmo, Calif., guilty of engaging in monetary transactions in criminally derived property, making false […]
ResMed posts strong 2Q growth
ResMed (NYSE:RMD) shares crept up today on second-quarter results that soundly beat the consensus forecast. The San Diego–based respiratory treatment device maker posted profits of $160.6 million, or $1.10 per share, on sales of $736.2 million for the three months ended Dec. 31, 2019, for a 28.9% bottom-line gain on sales growth of 13.1%. Adjusted to […]
Edwards Lifescience boosts 2020 guidance amid strong TAVR sales
Edwards Lifesciences (NYSE:EW) saw its stock jump in after-hours trading today after the company boosted its 2020 guidance amid positive fourth-quarter TAVR sales. The Irvine, Calif.–based cardio device and critical care monitoring company’s Q4 results were mixed. But there was also the news that worldwide TAVR sales were up 30% year-over-year in Q4, to $763 million, […]
Myomo announces 1-for-30 stock split, sees shares drop
Commercial-stage medical robotics company Myomo (NYSE:MYO) shares plummeted today after it announced the decision of its board of directors to effect a reverse stock split of the company’s common stock at a 1-for-30 ratio. Shares of MYO were down nearly –4% to $8.70 per share at market close today. The decision followed approval of a reverse […]
Danaher up on strong Q4 results, including life sciences and diagnostics
Danaher (NYSE:DHR) shares crept up today on big fourth-quarter gains that topped the consensus forecast. The Washington D.C.–based company posted profits of $1.275 billion, or $1.73 per share, on sales of $4.868 billion for the three months ended Dec. 31, 2019, for a 70.7% bottom-line gain on sales growth of 5.7%. Adjusted to exclude one-time items, […]
GE Healthcare is playing an important role in its parent’s turnaround
General Electric (NYSE:GE) stock jumped 10% after the industrial conglomerate posted Street-beating Q4 results, with CEO Larry Culp describing the company’s healthcare and aviation businesses as “exceptional franchises.” GE shares were down about nearly 3% to 12.56 apiece by midday trading today, a day after they shot up to $12.94 on the earnings news. Boston-based GE […]
MassDevice Network
@MassDevice
LinkedIn
YouTube